As of 2024-12-15, the Relative Valuation of Passage Bio Inc (PASG) is (30.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.78 USD, the upside of Passage Bio Inc based on Relative Valuation is -3968.7%.
The range of the Relative Valuation is (31.05) - (34.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.9x - 44.8x | 34.8x |
| Forward P/E multiples | 19.3x - 30.6x | 19.6x |
| Fair Price | (31.05) - (34.08) | (30.30) |
| Upside | -4065.4% - -4452.3% | -3968.7% |
| Date | P/E |
| 2024-12-10 | -0.71 |
| 2024-12-09 | -0.72 |
| 2024-12-06 | -0.70 |
| 2024-12-05 | -0.64 |
| 2024-12-04 | -0.67 |
| 2024-12-03 | -0.80 |
| 2024-12-02 | -0.91 |
| 2024-11-29 | -1.01 |
| 2024-11-27 | -0.60 |
| 2024-11-26 | -0.67 |
| 2024-11-25 | -0.56 |
| 2024-11-22 | -0.45 |
| 2024-11-21 | -0.48 |
| 2024-11-20 | -0.46 |
| 2024-11-19 | -0.43 |
| 2024-11-18 | -0.42 |
| 2024-11-15 | -0.47 |
| 2024-11-14 | -0.53 |
| 2024-11-13 | -0.52 |
| 2024-11-12 | -0.60 |
| 2024-11-11 | -0.58 |
| 2024-11-08 | -0.55 |
| 2024-11-07 | -0.58 |
| 2024-11-06 | -0.58 |
| 2024-11-05 | -0.56 |
| 2024-11-04 | -0.54 |
| 2024-11-01 | -0.57 |
| 2024-10-31 | -0.55 |
| 2024-10-30 | -0.56 |
| 2024-10-29 | -0.57 |
| 2024-10-28 | -0.60 |
| 2024-10-25 | -0.54 |
| 2024-10-24 | -0.58 |
| 2024-10-23 | -0.52 |
| 2024-10-22 | -0.53 |
| 2024-10-21 | -0.53 |
| 2024-10-18 | -0.52 |
| 2024-10-17 | -0.54 |
| 2024-10-16 | -0.53 |
| 2024-10-15 | -0.52 |
| 2024-10-14 | -0.54 |
| 2024-10-11 | -0.54 |
| 2024-10-10 | -0.53 |
| 2024-10-09 | -0.51 |
| 2024-10-08 | -0.55 |
| 2024-10-07 | -0.54 |
| 2024-10-04 | -0.58 |
| 2024-10-03 | -0.54 |
| 2024-10-02 | -0.60 |
| 2024-10-01 | -0.58 |